Ipca Laboratories has acquired 100 per cent share capital of Onyx Research Chemicals Ltd, holding company of Onyx Scientific Ltd, through its wholly owned subsidiary Ipca Laboratories UK Ltd. The acquisition brings together two contract manufacturing organisations to better serve their customers on a global basis.
Onyx Scientific has been a chemistry solutions provider for over a decade and will continue to operate out of the Silverbriar (Sunderland, UK) facility under the Onyx Scientific trade name. Onyx's capabilities in chemistry services for medicinal, preclinical and phase-I/II programmes will dovetail effectively with Ipca's capabilities in supporting phase II to commercial scale programmes.
Onyx Scientific, founded in the year 2000, is one of the well known chemistry services companies in Europe and is a preferred supplier to several large pharma and biotech customers. Onyx offers custom synthesis, solid state chemistry, scale-up and cGMP manufacturing up to a few kilogram levels.